Differential effects of cyclooxygenase pathway metabolites on cytokine production by T lymphocytes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 3, 1997, Pages 177-184

  Della Bella, S ^a,b   Molteni, M ^a   Compasso, S ^a   Zulian, C ^a   Vanoli, M ^a   Scorza, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CYTOKINE; ILOPROST; INTERLEUKIN 2; INTERLEUKIN 6; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; ARACHIDONIC ACID; DRUG DERIVATIVE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; PROSTAGLANDIN ENDOPEROXIDE; THROMBOXANE A2;

ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; ADULT; BIOSYNTHESIS; DRUG EFFECT; IMMUNOLOGY; KINETICS; METABOLISM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADJUVANTS, IMMUNOLOGIC; ADULT; ARACHIDONIC ACID; CYTOKINES; DINOPROSTONE; HUMANS; ILOPROST; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-6; KINETICS; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; T-LYMPHOCYTES; THROMBOXANE A2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030610890     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90531-7     Document Type: Article

References (39)

1. Leung K. H., Mihich E. Prostaglandin modulation of development of cell-mediated immunity in culture. Nature 1980; 288: 597-600.
2. Snyder D. S., Beller D. I., Unanue E. R. Prostaglandins modulate macrophage Ia expression. Nature 1982; 299: 163-165.
3. Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol 1983; 3: 295-315.
4. Goodwin J. S. Immunomodulation by eicosanoids and anti-inflammatory drugs. Curr Opin Immunol 1989; 2: 264-268.
5. Goodwin J. S., Atluro D., Sierakowski S., Lianos E. A. Mechanism of action of glucocorticosteroids. J Clin Invest 1986; 77: 1244-1250.
6. Johnson H. M., Torres B. A. Leukotrienes: positive signals for regulation of gamma-IFN production. J Immunol 1984; 132: 413-416.
7. 2. J Immunol 1990; 145: 2616-2625.
8. 2 effects on human suppressor cell function and on interleukin 2 function. J Immunol 1982; 129: 2469-2473.
9. Walker C., Kristensen F., Bettens F., DeWeck A. L. Lymphokine regulation of activated (G1) lymphocytes. J Immunol 1983; 130: 1770-1773.
10. 2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur J Immunol 1988; 18: 1791-1796.
11. Phipps R. P., Stein S. H., Roper R. L. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991; 12: 349-352.
12. Humes J. L., Bonney R.J., Pelus L., et al. Macrophages synthesise and release prostaglandins in response to inflammatory stimuli. Nature 1977; 269: 149-151.
13. Brune K., Glatt M., Kalin H., Peskar B. A. Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature 1978; 274: 261-263.
14. Pelus L. M., Bockman R. S. Increased prostaglandin synthesis by macrophages from tumor-bearing mice. J Immunol 1979; 123: 2118-2125.
15. Tripp C. S., Wyche A., Unanue E. R., Needleman P. The functional significance of the regulation of macrophage Ia expression by endogenous arachidonate metabolites in vitro. J Immunol 1986; 137: 3915-3920.
16. Rouzer C. A., Scott W. A., Hamill A. L., Cohn Z. A. Dynamics of leukotriene C production by macrophages. J Exp Med 1980; 152: 1236-1247.
17. Fels A. O. S., Pawlowski N. A., Cramer E. B., King T. K. C., Cohn Z. A., Scott W. A. Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci USA 1982; 79: 7866-7874.
18. Nichols F. C., Garrison S. W. Interferon-gamma potentiation of lypopolysaccharide-induced eicosanoid release from human monocytes. J Interf Res 1987; 7: 121-129.
19. Scott W. A., Pawlowski N. A., Murray H. W., Andreach M., Zrike J., Cohn Z. A. Regulation of arachidonic acid metabolism by macrophage activation. J Exp Med 1982; 155: 1148-1160.
20. Tripp C. S., Leahy K. M., Needleman P. Thromboxane synthase is preferentially conserved in activated mouse peritoneal macrophages. J Clin Invest 1985; 76: 898-901.
21. Marcinkiewicz J. In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6. Cytokine 1991; 3: 327-332.
22. Aderem A. A., Cohn Z. A. Calcium ionophore synergizes with bacterial lipopolysaccharides in activating macrophage arachidonic acid metabolism. J Exp Med 1988; 167: 623-631.
23. Pawlowski N. A., Kaplan G., Hamill A. L., Cohn Z. A., Scott W. A. Arachidonic acid metabolism by human monocytes. J Exp Med 1983; 158: 393-412.
24. Nusing R., Ullrich V. Regulation of cyclooxygenase and thromboxane synthase in human monocytes. Eur J Biochem 1992; 206: 131-136.
25. Zurier R. B. Prostaglandins, leukotrienes and related compounds. In: Kelley W. N., Harris E. D., Ruddy S., Sledge C. B., eds. Textbook of Rheumatology. Philadelphia: WB Saunders 1993: 201-212.
26. Moncada S., Higgs E. A., Vane J. R. Human arterial and venous tissue generates prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977; 1: 18-20.
27. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994-2998.
28. Coleman R. A. Methods in prostanoid receptor classification. In: Benedetto C., McDonald-Gibson R. G., Nigam S and Slater T. F., eds. Prostaglandins and related substances. Oxford Washington: IRL Press 1987: 267-303.
29. 2-receptors and molecular mechanisms in platelets and vasculature: state of the art. Pharm Res Comm 1987; 19: 735-765.
30. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21: 77-80.
31. Pellegrino O., Ferrone S. Isolation of human B and T lymphocytes by resetting peripheral lymphocytes with 2-aminoethylisothiouronium bromide (AET) treated sheep red blood cells. In: Duquesnoy R. J., Fuller C., eds. The First HLA Workshop of the Americas. Bethesda: Dhew Press, 1975: 176-178.
32. Thiele D. L., Lipsky P. E. Modulation of natural killer cell function by L-Leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells. J Immunol 1985; 134: 786-793.
33. Thiele D. L., Lipsky P. E. The immunosuppressive activity of L-Leucyl-L-Leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol 1986; 136: 1038-1048.
34. Marcinkiewicz J., Chain B. M. Differential cytokine regulation by eicosanoids in T cells primed by contact sensitisation with TNP. Cell Immunol 1993; 149: 303-314.
35. 2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. J Leukoc Biol 1989; 45: 416-421.
36. 2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin-1 beta, from human macrophages. Immunol Letters 1991; 31: 85-90.
37. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. Exp Med 1993; 178: 1825-1830.
38. 2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of maior histocompatibility allopeptides. J Exp Med 1994; 180: 1967-1972.
39. Sravan Kumar G., Das U. N. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 331-334.